C9740 Transprostatic Implant | HCPCS Reimbursement

HCPCS Level II code C9740 represents cystourethroscopy with insertion of transprostatic implants (4 or more). This endoscopic urologic procedure is used to address lower urinary tract obstruction by placing multiple implants within the prostate through a transurethral approach. Nationally, the code matters for surgical billing, facility planning, and coverage determinations as use of implantable technologies expands in benign prostatic hyperplasia and related conditions.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the procedure, the typical sites of service where it is performed, and the common payer policies that affect coverage and claims handling for implant-based cystourethroscopy. The publication summarizes benchmark metrics where available, describes typical documentation and coding considerations tied to the service description, and flags areas where policy updates or coding guidance commonly arise. Data not available in the input is noted where applicable.

Billing Code Overview

HCPCS Level II code C9740 describes a cystourethroscopy with insertion of transprostatic implant, 4 or more implants. This procedure involves endoscopic visualization of the bladder and urethra with placement of multiple transprostatic implants intended to treat lower urinary tract symptoms related to prostatic obstruction or similar indications.

Service type: Endoscopic urologic surgical procedure
Typical site of service: Hospital outpatient department or ambulatory surgical center

Clinical Context

A 68-year-old male with bothersome lower urinary tract symptoms (urinary frequency, nocturia, weak stream) and objective evidence of benign prostatic hyperplasia (BPH) is evaluated after failing medical therapy with alpha-blockers and 5-alpha reductase inhibitors. Diagnostic workup includes history and physical, serum PSA, urinalysis, uroflowmetry showing reduced peak flow (Qmax), and transrectal ultrasound confirming prostatic enlargement. The urology team schedules a cystourethroscopy with transprostatic implant insertion device (typically performed under monitored anesthesia care or general anesthesia) to place multiple implants to open prostatic urethral obstruction. The procedure is performed in an ambulatory surgery center or hospital outpatient department; the operator performs cystourethroscopy to visualize the urethra and bladder, inserts a transprostatic delivery device under cystoscopic guidance, and deploys four or more implants into the prostate tissue to create and maintain a patent prostatic urethral channel. Typical intraoperative workflow includes cystoscopic evaluation, implant deployment, hemostasis assessment, and catheter placement or short period of observation post-procedure. Postoperative course includes brief recovery, voiding trial prior to discharge, and urology follow-up for symptom assessment and implant surveillance.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier — standard service	Use when no special circumstance or modifier applies.

Taxonomy Code	Specialty	Notes
`208000000X`	Urology	Primary specialty performing cystourethroscopy with transprostatic implants.
`208100000X`	Female Pelvic Medicine & Reconstructive Surgery	May perform endoscopic prostatic procedures in select practices caring for complex lower urinary tract disorders (note: primarily male patients are typical).
`208VP0000X`	Vascular & Interventional Radiology	May be involved in percutaneous prostate procedures in centers using image-guided implantation techniques.
`363L00000X`	Ambulatory Surgical Center	Facility taxonomy for sites commonly providing this outpatient procedure.
`261QM0800X`	Anesthesiology	Provides monitored anesthesia care or general anesthesia as required for patient condition.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N40.0`	Enlarged prostate (benign prostatic hyperplasia)	Primary indication for transprostatic implant placement to relieve bladder outlet obstruction.
`R33.9`	Retention of urine, unspecified	Acute or chronic urinary retention may prompt intervention with prostatic implants to restore voiding.
`N13.8`	Other obstructive and reflux uropathy	Used when obstruction affecting lower urinary tract contributes to symptoms addressed by implants.
`R39.15`	Urgency of urination	Represents lower urinary tract symptom that may be improved after urethral dilation by implants.
`N36.9`	Urethral disorder, unspecified	May be used when urethral pathology contributes to obstruction and requires diagnostic cystourethroscopy and intervention.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`52000`	Cystourethroscopy, diagnostic; female or male, with or without irrigation and/or collection of specimen(s)	Diagnostic cystourethroscopy performed prior to or as part of implant placement for visualization of urethra and bladder.
`52204`	Cystourethroscopy, with removal of foreign body, with or without dilation (separate procedure)	May be used if removal of an obstructing lesion or prior implant material is required before implantation.
`52647`	Transurethral electrosurgical resection of prostate, including control of postprocedural bleeding, complete (for benign prostatic hyperplasia)	An alternative or preceding therapeutic option for BPH; listed for clinical workflow comparison when implant placement is not performed.
`54240`	Implantation of prosthetic material into the scrotum or perineum (note: used here for contextual relation to implant-based urologic procedures)	Related as representative of coding for implantable urologic devices when device-specific codes do not apply.
`99223`	Initial hospital care, typically 70 minutes or more	Represents typical inpatient or observation initial evaluation code when perioperative management requires hospital admission or extended evaluation.

OpenPayer

Summary & Overview

HCPCS C9740: Cystourethroscopy with Transprostatic Implants, 4+